Bio SB performs R&D, production, distribution and marketing of unique products for Immunohistochemistry (IHC), Immunocytochemistry (ICC), Fluorescent in situ hybridization (FISH) and Chromogenic in situ hybridization (CISH) technologies that meet the highest international standards for applications in Molecular Pathology, Cancer Research, Microbiology, Immunology and Genetics. BIO SB manufactures and develops products in accordance with FDA QSR 21 CFR Part 820 cGMP and ISO 13485:2016 standards. These guidelines enable us to produce an IVD product that meets the highest in vitro diagnostic standards.
|February 8th – 12th, 2020||The 14th Annual International Retreat on Applied IHC & Molecular Pathology||Website|
|September 20th – 25th, 2019||NSH Symposium / Convention, New Orleans, Louisiana||Website|
|May 23rd – 26th, 2019||American Society for Mohs Surgery 2019 Annual Meeting, Naples, Florida||Website|
|May 2nd – 5th, 2019||American College of Mohs Surgery 2019 Annual Meeting, Baltimore, Maryland||Website|
|March 31st – April 3rd, 2019||AACR 2019 Annual Meeting, Atlanta, Georgia||Website|
|March 18th – 20th, 2019||USCAP 2019 Annual Meeting, National Harbor, Maryland||Website|